Doximity outlines FY 2027 revenue of $678M-$683M as AI search reaches 8-figure bookings
FROM THE WIRE · SEEKINGALPHA.COM
Earnings Call Insights: Doximity (DOCS) Q2 fiscal 2027 MANAGEMENT VIEW * "Revenue was $175 million in Q2, up 4% year-over-year" (Co-Founder, CEO & Chairperson Jeffrey Tangney) and "our Q2 adjusted EBITDA margin was 51% or $89 million" (CEO Tangney), alongside "over 6x growth…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralAnnual guidance and AI usage growth matter for DOCS, a mid-sized healthcare tech stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01The CEO reported Q2 revenue of $175 million, up 4% year over year.
- 02Adjusted EBITDA margin was 51%, or $89 million.
- 03The company launched DoseCheck, a verifier for medication safety in AI dose queries.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets